🇺🇸 FDA
Pipeline program

Natrunix 400 mg

PT067

Phase 2 mab active

Quick answer

Natrunix 400 mg for Rheumatoid Arthritis is a Phase 2 program (mab) at XBiotech with 1 ClinicalTrials.gov record(s).

Program details

Company
XBiotech
Indication
Rheumatoid Arthritis
Phase
Phase 2
Modality
mab
Status
active

Clinical trials